Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease

被引:422
作者
Endler, G
Klimesch, A
Sunder-Plassmann, H
Schillinger, M
Exner, M
Mannhalter, C
Jordanova, N
Christ, G
Thalhammer, R
Huber, K
Sunder-Plassmann, R
机构
[1] Univ Vienna, Sch Med, Dept Lab Med, Vienna, Austria
[2] Univ Vienna, Dept Internal Med 2, Div Angiol, Vienna, Austria
[3] Univ Vienna, AKH Wien, Div Cardiol, Dept Internal Med 2, Vienna, Austria
关键词
mean platelet volume; myocardial infarction; interleukin; 6; polymorphism;
D O I
10.1046/j.1365-2141.2002.03441.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
After rupture of an arteriosclerotic plaque in a coronary artery, platelets play a crucial role in the subsequent thrombus formation, leading to myocardial infarction. An increased mean platelet volume (MPV), as an indicator of larger, more reactive platelets, may represent a risk factor for myocardial infarction. However, this hypothesis is still controversial and most studies addressing the role of MPV were performed comparing patients suffering from myocardial infarction with healthy controls. We intended to identify patients at high risk of suffering myocardial infarction in a group of patients with known coronary artery disease. One hundred and eighty-five consecutive patients with stable coronary artery disease were compared with 188 individuals who had suffered myocardial infarction. Patients within the highest quintile of MPV (greater than or equal to 11.6 fl) had a significantly higher risk of experiencing a myocardial infarction compared with patients within the lowest quintile (OR = 2.6, 95% CI 1.3-5.1) in a multivariate analysis that included sex, age, body mass index, hyperlipidaemia, hypertension, smoking and diabetes mellitus. Our results indicate that patients with pre-existing coronary artery disease and an increased MPV (greater than or equal to 11.6 fl) are at higher risk of myocardial infarction. These patients can be easily identified during routine haematological analysis and could possibly benefit from preventive treatment.
引用
收藏
页码:399 / 404
页数:6
相关论文
共 34 条
[1]  
BATH PMW, 1993, THROMB HAEMOSTASIS, V70, P687
[2]   INCREASED PLATELET VOLUME AND PLATELET MASS IN PATIENTS WITH ATHEROSCLEROTIC RENAL-ARTERY STENOSIS [J].
BATH, PMW ;
MISSOURIS, CG ;
BUCKENHAM, T ;
MACGREGOR, GA .
CLINICAL SCIENCE, 1994, 87 (02) :253-257
[3]   Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis [J].
Brown, AS ;
Hong, Y ;
deBelder, A ;
Beacon, H ;
Beeso, J ;
Sherwood, R ;
Edmonds, M ;
Martin, JF ;
Erusalimsky, JD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (04) :802-807
[4]  
CORASH L, 1977, BLOOD, V49, P71
[5]   EFFECTS OF THE RECOMBINANT HEMATOPOIETIC GROWTH-FACTORS INTERLEUKIN-3, INTERLEUKIN-6, STEM-CELL FACTOR, AND LEUKEMIA INHIBITORY FACTOR ON THE MEGAKARYOCYTIC DIFFERENTIATION OF CD34+ CELLS [J].
DEBILI, N ;
MASSE, JM ;
KATZ, A ;
GUICHARD, J ;
BRETONGORIUS, J ;
VAINCHENKER, W .
BLOOD, 1993, 82 (01) :84-95
[6]   A common C→T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity [J].
Endler, G ;
Exner, M ;
Mannhalter, C ;
Meier, S ;
Ruzicka, K ;
Handler, S ;
Panzer, S ;
Wagner, O ;
Quehenberger, P .
THROMBOSIS RESEARCH, 2001, 101 (04) :255-260
[7]   The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis [J].
Fishman, D ;
Faulds, G ;
Jeffery, R ;
Mohamed-Ali, V ;
Yudkin, JS ;
Humphries, S ;
Woo, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1369-1376
[8]   Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study [J].
Georges, JL ;
Loukaci, V ;
Poirier, O ;
Evans, A ;
Luc, G ;
Arveiler, D ;
Ruidavets, JB ;
Cambien, F ;
Tiret, L .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (5-6) :300-305
[9]   THE CONTROL OF MEGAKARYOCYTE PLOIDY AND PLATELET PRODUCTION - BIOLOGY AND PATHOLOGY [J].
GLADWIN, AM ;
MARTIN, JF .
INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 (04) :291-298
[10]   PLATELET SIZE, FIBRINOGEN AND LIPOPROTEIN(A) IN CORONARY HEART-DISEASE [J].
HALBMAYER, WM ;
HAUSHOFER, A ;
RADEK, J ;
SCHON, R ;
DEUTSCH, M ;
FISCHER, M .
CORONARY ARTERY DISEASE, 1995, 6 (05) :397-402